探討布地奈德治療變應(yīng)性鼻炎患者后鼻分泌物嗜酸粒細(xì)胞與肺功能的相關(guān)性
發(fā)布時(shí)間:2018-10-31 13:16
【摘要】:目的:探討變應(yīng)性鼻炎(AR)患者鼻用布地奈德治療后嗜酸粒細(xì)胞(EOS)與肺功能的相關(guān)性。方法:按照標(biāo)準(zhǔn)選取50例中重度AR患者(AR組),50例正常者(對(duì)照組),對(duì)2組行肺功能及鼻分泌物EOS檢查。AR組采用布地奈德+氯雷他定治療3個(gè)月后再次行肺功能及EOS檢查,分析兩者之間的變化趨勢。結(jié)果:AR組患者EOS均較對(duì)照組升高(P0.05),且肺功能最大呼氣中期流量(MMEF)與鼻分泌物EOS呈負(fù)相關(guān)(r=-0.945);治療后AR患者EOS較治療前降低,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。經(jīng)布地奈德治療后,AR組患者EOS下降與肺功能上升的數(shù)值變化呈正相關(guān)(r=0.803)。結(jié)論:AR患者鼻分泌物EOS越高,其肺功能下降越明顯,經(jīng)治療后,AR患者鼻分泌物EOS下降越多,其肺功能改善越大。
[Abstract]:Aim: to investigate the correlation between eosinophil (EOS) and lung function in patients with allergic rhinitis (AR) after budesonide treatment. Methods: 50 patients with moderate and severe AR (AR group) and 50 normal subjects (control group) were selected according to the standard. Pulmonary function and nasal secretions were examined by EOS in two groups, and lung function and EOS were examined again in AR group after 3 months of budesonide loratadine therapy, and the change trend between them was analyzed. Results: EOS in AR group was significantly higher than that in control group (P0.05), and the maximal expiratory flow (MEF) (MMEF) was negatively correlated with nasal secretion EOS (r-0.945). After treatment, the EOS of AR patients was lower than that before treatment, the difference was statistically significant (P0.05). After budesonide treatment, there was a positive correlation between the decrease of EOS and the increase of pulmonary function in AR group (r = 0.803). Conclusion: the higher the EOS of nasal secretions in AR patients, the more obvious the decrease of pulmonary function. After treatment, the more EOS in nasal secretions of AR patients is decreased, the greater the improvement of pulmonary function is.
【作者單位】: 青島經(jīng)濟(jì)技術(shù)開發(fā)區(qū)第一人民醫(yī)院耳鼻咽喉科;青島大學(xué)醫(yī)學(xué)院附屬醫(yī)院耳鼻咽喉科;
【分類號(hào)】:R765.21
[Abstract]:Aim: to investigate the correlation between eosinophil (EOS) and lung function in patients with allergic rhinitis (AR) after budesonide treatment. Methods: 50 patients with moderate and severe AR (AR group) and 50 normal subjects (control group) were selected according to the standard. Pulmonary function and nasal secretions were examined by EOS in two groups, and lung function and EOS were examined again in AR group after 3 months of budesonide loratadine therapy, and the change trend between them was analyzed. Results: EOS in AR group was significantly higher than that in control group (P0.05), and the maximal expiratory flow (MEF) (MMEF) was negatively correlated with nasal secretion EOS (r-0.945). After treatment, the EOS of AR patients was lower than that before treatment, the difference was statistically significant (P0.05). After budesonide treatment, there was a positive correlation between the decrease of EOS and the increase of pulmonary function in AR group (r = 0.803). Conclusion: the higher the EOS of nasal secretions in AR patients, the more obvious the decrease of pulmonary function. After treatment, the more EOS in nasal secretions of AR patients is decreased, the greater the improvement of pulmonary function is.
【作者單位】: 青島經(jīng)濟(jì)技術(shù)開發(fā)區(qū)第一人民醫(yī)院耳鼻咽喉科;青島大學(xué)醫(yī)學(xué)院附屬醫(yī)院耳鼻咽喉科;
【分類號(hào)】:R765.21
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 李松桃;王導(dǎo)新;;慢性嗜酸粒細(xì)胞肺炎臨床診治研究進(jìn)展[J];中華哮喘雜志(電子版);2012年04期
2 李緒瓊;;蠕蟲感染與嗜酸粒細(xì)胞增多(綜述)[J];浙江醫(yī)科大學(xué)學(xué)報(bào);1980年02期
3 李緒瓊;張怡瑾;朱永泉;;嗜酸粒細(xì)胞與癌(綜述)[J];浙江醫(yī)科大學(xué)學(xué)報(bào);1981年06期
4 直炳攸;;嗜酸粒細(xì)胞及嗜酸粒細(xì)胞過多綜合癥[J];四川解剖學(xué)雜志;1984年01期
5 倪子俞;凌蘇;孟紓;朱光復(fù);;單純性嗜酸粒細(xì)胞性肺病25例臨床分析[J];哈爾濱醫(yī)藥;1987年02期
6 徐大為;敖忠芳;;嗜酸粒細(xì)胞和惡性腫瘤[J];國外醫(yī)學(xué).輸血及血液學(xué)分冊(cè);1988年05期
7 趙廣東;嗜酸粒細(xì)胞性肺浸潤[J];日本醫(yī)學(xué)介紹;1994年09期
8 陳e,,硴镒
本文編號(hào):2302331
本文鏈接:http://sikaile.net/yixuelunwen/wuguanyixuelunwen/2302331.html
最近更新
教材專著